CareLit Fachartikel
Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): pooled data from six clinical trials
DS Koschel, L Lancaster, P Hernandez, Y Inoue, D Wachtlin, L Loaiza, CS Conoscenti, M Quaresma, S Stowasser, L Richeldi · Pneumologie · 2019 · Heft S 01 S 01
Dokument
1194785
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF): pooled data from six clinical trials
Schlagworte
Safety
Tolerability
Nintedanib
Patients
Idiopathic
Pulmonary
Fibrosis
Pooled
Clinical
Trials
Pneumologie